38,100 Shares in Vivos Therapeutics, Inc. (NASDAQ:VVOS) Acquired by Cutter & CO Brokerage Inc.

Cutter & CO Brokerage Inc. bought a new stake in Vivos Therapeutics, Inc. (NASDAQ:VVOS) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 38,100 shares of the company’s stock, valued at approximately $163,000. Cutter & CO Brokerage Inc. owned approximately 0.65% of Vivos Therapeutics as of its most recent SEC filing.

Analyst Upgrades and Downgrades

VVOS has been the subject of a number of analyst reports. Alliance Global Partners dropped their price objective on shares of Vivos Therapeutics from $8.25 to $6.00 and set a “buy” rating for the company in a report on Tuesday, November 19th. Ascendiant Capital Markets reissued a “buy” rating and issued a $6.60 price target on shares of Vivos Therapeutics in a research note on Wednesday, November 20th.

Vivos Therapeutics Stock Up 3.0 %

NASDAQ:VVOS opened at $3.45 on Thursday. Vivos Therapeutics, Inc. has a 52 week low of $1.91 and a 52 week high of $6.28. The stock’s fifty day moving average is $4.37 and its two-hundred day moving average is $3.49. The company has a market capitalization of $20.32 million, a P/E ratio of -0.61 and a beta of 7.47.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.